Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data ...

Helio Genomics ("Helio" or "the Company"), a trailblazer in AI-powered, blood-based cancer diagnostics, has appointed Dr.

Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 ...

Boehringer Ingelheim and SoundTalks end their partnership, but what does this mean for pig farmers? Find out about the future ...

THE German-Philippine Chamber of Commerce and Industry (GPCCI), in partnership with the German Embassy-Manila and Boehringer Ingelheim Philippines, convened a multi-stakeholder roundtable to address ...

Mainz, 22 July 2025. Boehringer Ingelheim Stiftung commits 7 million euros to support the EMBL Imaging Centre in Heidelberg. Boehringer Ingelheim Stiftung, Dr Friederike Keggenhoff, Officer, Web: ...

This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...

The advanced heart failure market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical companies such as ...

LEO Pharma and Boehringer Ingelheim have entered into a partnership to commercialise and advance the development of ...

Boehringer Ingelheim announces the start of the THULITE Phase II clinical study. It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral treatment to improve vision ...

Lupin is releasing Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, which are the generic of Boehringer ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...